Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis.

Amezcua L, Smith JB, Gonzales EG, Haraszti S, Langer-Gould A.

Neurology. 2020 Apr 7;94(14):e1548-e1556. doi: 10.1212/WNL.0000000000009210. Epub 2020 Mar 9.

PMID:
32152131
2.

Race and ethnicity on MS presentation and disease course.

Amezcua L, McCauley JL.

Mult Scler. 2020 Jan 22:1352458519887328. doi: 10.1177/1352458519887328. [Epub ahead of print]

PMID:
31965878
3.

Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).

Okai AF, Amezcua L, Berkovich RR, Chinea AR, Edwards KR, Steingo B, Walker A, Jacobs AK, Daizadeh N, Williams MJ; CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators.

Neurol Ther. 2019 Dec;8(2):367-381. doi: 10.1007/s40120-019-00159-2. Epub 2019 Oct 25.

4.

The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.

Beecham AH, Amezcua L, Chinea A, Manrique CP, Rubi C, Isobe N, Lund BT, Santaniello A, Beecham GW, Burchard EG, Comabella M, Patsopoulos N, Fitzgerald K, Calabresi PA, De Jager P, Conti DV, Delgado SR, Oksenberg JR, McCauley JL.

Mult Scler. 2019 Aug 1:1352458519863764. doi: 10.1177/1352458519863764. [Epub ahead of print]

PMID:
31368393
5.

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC).

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 28;6(5):e583. doi: 10.1212/NXI.0000000000000583. eCollection 2019 Sep.

6.

Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.

Barisano G, Bigjahan B, Metting S, Cen S, Amezcua L, Lerner A, Toga AW, Law M.

AJNR Am J Neuroradiol. 2019 Aug;40(8):1274-1281. doi: 10.3174/ajnr.A6148. Epub 2019 Jul 25.

PMID:
31345942
7.

Women's Health: Contemporary Management of MS in Pregnancy and Post-Partum.

Tisovic K, Amezcua L.

Biomedicines. 2019 Apr 19;7(2). pii: E32. doi: 10.3390/biomedicines7020032. Review.

8.

Rituximab during pregnancy in neuromyelitis optica: A case report.

Miranda-Acuña J, Rivas-Rodríguez E, Levy M, Ansari M, Stone R, Patel V, Amezcua L.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(2):e542. doi: 10.1212/NXI.0000000000000542. eCollection 2019 Mar. No abstract available.

9.

Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis.

Amezcua L, Beecham AH, Delgado SR, Chinea A, Burnett M, Manrique CP, Gomez R, Comabella M, Montalban X, Ortega M, Tornes L, Lund BT, Islam T, Conti D, Oksenberg JR, McCauley JL.

Ann Clin Transl Neurol. 2018 Sep 23;5(11):1362-1371. doi: 10.1002/acn3.646. eCollection 2018 Nov.

10.

Multiple Sclerosis Mortality by Race/Ethnicity, Age, Sex, and Time Period in the United States, 1999-2015.

Amezcua L, Rivas E, Joseph S, Zhang J, Liu L.

Neuroepidemiology. 2018;50(1-2):35-40. doi: 10.1159/000484213. Epub 2018 Jan 16.

PMID:
29339633
11.

Ethnic Considerations and Multiple Sclerosis Disease Variability in the United States.

Rivas-Rodríguez E, Amezcua L.

Neurol Clin. 2018 Feb;36(1):151-162. doi: 10.1016/j.ncl.2017.08.007. Review.

PMID:
29157396
12.

FOD Restoration for Enhanced Mapping of White Matter Lesion Connectivity.

Sun W, Amezcua L, Shi Y.

Med Image Comput Comput Assist Interv. 2017 Sep;10433:584-592. doi: 10.1007/978-3-319-66182-7_67. Epub 2017 Sep 4.

13.

MS in self-identified Hispanic/Latino individuals living in the US.

Amezcua L, Oksenberg JR, McCauley JL.

Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317725103. doi: 10.1177/2055217317725103. eCollection 2017 Jul-Sep. Review.

14.

Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.

Rito Y, Flores J, Fernández-Aguilar A, Escalante-Membrillo C, Barboza MA, Amezcua L, Corona T.

Acta Neurol Belg. 2018 Mar;118(1):47-52. doi: 10.1007/s13760-017-0834-3. Epub 2017 Oct 3.

PMID:
28975580
15.

Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.

Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH.

Neurology. 2017 Sep 26;89(13):1330-1337. doi: 10.1212/WNL.0000000000004412. Epub 2017 Aug 30.

16.

Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.

Amezcua L, Nelson F.

Neurotherapeutics. 2017 Oct;14(4):945-951. doi: 10.1007/s13311-017-0560-9. Review.

17.

Perceptions of Multiple Sclerosis in Hispanic Americans: Need for Targeted Messaging.

Obiwuru O, Joseph S, Liu L, Palomeque A, Tarlow L, Langer-Gould AM, Amezcua L.

Int J MS Care. 2017 May-Jun;19(3):131-139. doi: 10.7224/1537-2073.2015-081.

18.

Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial.

Berkovich R, Bakshi R, Amezcua L, Axtell RC, Cen SY, Tauhid S, Neema M, Steinman L.

Ther Adv Neurol Disord. 2017 Jan;10(1):3-17. doi: 10.1177/1756285616670060. Epub 2016 Oct 19.

19.

Pro-atherogenic mediators and subclinical atherogenesis are related to epicardial adipose tissue thickness in patients with cardiovascular risk.

Peraza-Zaldívar JA, Suárez-Cuenca JA, Aceves-Millán R, Ixcamparij-Rosales C, Amezcua L, Pérez-Cabeza de Vaca R, Guerrero-Celis N, Melchor-López A, Mondragón-Terán P, Alcaráz-Estrada SL.

J Int Med Res. 2017 Dec;45(6):1879-1891. doi: 10.1177/0300060516655245. Epub 2016 Aug 7.

20.

Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.

Langille MM, Islam T, Burnett M, Amezcua L.

J Child Neurol. 2016 Jul;31(8):1068-73. doi: 10.1177/0883073816638754. Epub 2016 Mar 28.

PMID:
27021143

Supplemental Content

Loading ...
Support Center